PRL‑8‑53
Phenyl-methyl-piperidinyl benzoate, 1970s, one published human memory trial.
The links above are labelled third-party affiliate links. MolekulaX does not sell and does not verify product quality.
WHAT IS PRL-8-53?
Detailed overview
PRL-8-53 (methyl-3-(2-(benzyl(methyl)amino)ethyl)benzoate) was patented in 1972 (Dr. Nikolaus Hansl, Creighton University). A single 1978 double-blind placebo-controlled human trial (n=47, Hansl & Mehler, PMID 418433) described statistically significant verbal-memory improvement, enhanced long- and short-term recall, and modest motor-control gains; effects stronger in older and initially low-performing subjects. Anecdotally also used for language learning and vocabulary retention. Mechanism: cholinergic signal enhancement + dopamine potentiation + mild serotonin inhibition (per the original patent). **High doses can produce convulsive effects, anxiety, insomnia**. No follow-up trials since → thin database.
Mechanism
Cholinergic + dopaminergic modulation
Half-life
No published human data
Legal status
Investigational, not approved
Safety
Side effects, stop signs, contraindications
Side effects · 7
- Anxiety and restlessness reported at higher doses
- Insomnia and disturbed sleep (cholinergic-dopaminergic stimulation)
- Tremor and shakiness at higher doses
- Mild sweating in some users
- Risk of convulsive, seizure-type activity at high doses (per patent)
- Highly variable individual response, unpredictable effect profile
- Unknown long-term safety, no follow-up human data
Contraindications · 6
- Avoid during pregnancy and breastfeeding (no safety data)
- Avoid with seizure disorders or epilepsy (potential to lower seizure threshold)
- Caution with anxiety disorders or sleep disturbance
- Increased risk when combined with other dopaminergic or cholinergic agents
- Unapproved experimental compound sold as an uncontrolled research chemical, avoid high doses
- Limited human data, consider only cautiously at low doses under supervision
Related Nootropics
Same therapeutic category
Telegram
Have a question about PRL‑8‑53?
Reach out to us on Telegram for a personalized stack. We'll be happy to help.
The information here is strictly for educational and scientific purposes. It does not replace medical advice or clinical consultation, and it does not encourage illegal substance or pharmaceutical use. Data is sourced. When in doubt, consult your doctor.